Combination therapy of semaglutide and metformin significantly decreases body weight, BMI, and waist-to-hip ratio versus metformin alone in overweight/obese women with PCOS.
Greater improvements in testosterone levels, visceral adiposity, and inflammatory marker CRP were observed with combination therapy.
Combination therapy enhanced menstrual cycle recovery and markedly increased natural pregnancy rates during follow-up.
